Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Olaf ThuerigenPeter Lichter

Abstract

Primary systemic therapy (PST) with gemcitabine (G), epirubicin (E), and docetaxel (Doc) has resulted in a pathologic complete response (pCR) in 26% of primary breast cancer patients. This study was aimed at the identification of a gene expression signature in diagnostic core biopsy tissue samples that predicts pCR. Core biopsy samples from patients with operable primary breast cancer, T2-4N0-2M0, enrolled onto two phase I and II trials evaluating GEDoc (n = 48) and GE sequentially followed by Doc (GEsDoc; n = 52) as PST were snap frozen and subjected to RNA expression profiling. A signature predicting pCR was discovered in the training set (GEsDoc) applying a support vector machine algorithm, and performance of this classifier was validated on the independent test set (GEDoc) by receiver operator characteristics analysis. We identified a signature consisting of 512 genes, which was enriched in genes involved in transforming growth factor beta and RAS-mediated signaling pathways, that predicts pCR with a sensitivity of 78%, a specificity of 90%, and an overall accuracy of 88% (95% CI, 75% to 95%). Apart from our signature, only HER2 overexpression was an independent predictor of pCR in multivariate analysis. In conclusion, our ...Continue Reading

References

Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B FisherH D Bear
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H M KuererS E Singletary
Aug 30, 2000·Nature·C M PerouD Botstein
Mar 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R C BastUNKNOWN American Society of Clinical Oncology Tumor Markers Expert Panel
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Feb 2, 2002·Nature·Laura J van 't VeerStephen H Friend
Mar 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ian C SmithKeith N Ogston
Dec 20, 2002·The New England Journal of Medicine·Marc J van de VijverRené Bernards
May 22, 2003·Computer Methods and Programs in Biomedicine·Georg Heinze, Meinhard Ploner
Jun 28, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Manfred KaufmannHans-Jörg Senn
Oct 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harry D BearUNKNOWN National Surgical Adjuvant Breast and Bowel Project Protocol B-27
Oct 28, 2003·The American Journal of Pathology·Andrey KorshunovPeter Lichter
May 12, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M AyersL Pusztai
Aug 17, 2004·Bioinformatics·Liat Ein-DorEytan Domany
Nov 3, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A SchneeweissG Bastert
Mar 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rebecca L Elliott, Gerard C Blobe
May 24, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Juliane HannemannMarc J van de Vijver
Aug 2, 2005·Nature Reviews. Cancer·Britta WeigeltLaura J van 't Veer
Aug 24, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roman RouzierLajos Pusztai
Oct 6, 2005·Laboratory Investigation; a Journal of Technical Methods and Pathology·Joerg SchlingemannMeinhard Hahn

❮ Previous
Next ❯

Citations

Jul 20, 2010·Analytical and Bioanalytical Chemistry·Nicole Schneiderhan-MarraThomas O Joos
Aug 24, 2011·Cancer Chemotherapy and Pharmacology·Denise Campos-ArroyoJorge Melendez-Zajgla
Feb 22, 2012·International Journal of Clinical Oncology·Fabrizio NelliEnzo Maria Ruggeri
Aug 17, 2010·Breast Cancer Research and Treatment·Agustí Barnadas
Mar 23, 2012·Breast Cancer Research and Treatment·Carole MassabeauAlain Fourquet
May 24, 2012·Molecular & Cellular Proteomics : MCP·Martin KlammerChristoph Schaab
Apr 9, 2009·Pharmacogenetics and Genomics·Soo-Chin LeeBoon-Cher Goh
Jan 14, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Joshua A BauerJennifer A Pietenpol
Jun 26, 2010·Breast Cancer Research : BCR·Joshua A BauerJennifer A Pietenpol
Mar 17, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Abigail S CaudleFunda Meric-Bernstam
Feb 4, 2014·Virchows Archiv : an International Journal of Pathology·Marc J van de Vijver
Mar 6, 2010·Breast Cancer Research and Treatment·Michael KnauerLaura J van 't Veer
Apr 22, 2009·Expert Review of Molecular Diagnostics·Andrea Staratschek-JoxJoachim L Schultze
Oct 6, 2006·Expert Opinion on Pharmacotherapy·Olga ModlichHans Bojar
Jun 12, 2012·Expert Opinion on Drug Metabolism & Toxicology·Sing-Huang Tan, Soo-Chin Lee
Feb 19, 2010·Expert Opinion on Drug Metabolism & Toxicology·Sing-Huang Tan, Soo-Chin Lee
May 30, 2009·Cancer Investigation·Romain BoidotSarab Lizard-Nacol
Dec 19, 2008·Cancer Investigation·Christina I Herold, P Kelly Marcom
Jun 22, 2011·Revista da Associação Médica Brasileira·Maria Aparecida Azevedo Koike FolgueiraRené Aloisio da Costa Vieira
Jun 29, 2010·Gynécologie, obstétrique & fertilité·A FratiC Coutant
May 30, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Hervé BonnefoiDavid Cameron
Feb 24, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S MookE J Rutgers
Oct 30, 2008·Clinica Chimica Acta; International Journal of Clinical Chemistry·Kathleen DeiterenAnne Marie Lambeir

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.